| 英文名称 | 中文名称 | CAS | MF |
|
anthraquinone-β-sulfonic
|
蒽醌-Β-磺酸
|
|
C14H7O2SO3H
|
|
ANTHRANILIC ACID, N-ACETYL-N-(DIMETHYLCARBAMOYLMETHYL)-, ETHYL ESTER
|
|
92648-99-2
|
|
|
anthranoylanthranilic acid
|
N-鄰胺苯甲醯胺苯甲酸
|
|
C22H15NO3
|
|
9,10-anthradiamine
|
二胺蒽
|
|
C14H12N2
|
|
anthraquinoline
|
蒽喹啉
|
224-98-6
|
C17H11N
|
|
1-anthrol
|
1-羥蒽
|
|
C14H10O
|
|
anthraflavine
|
蒽黃素
|
|
C14H8O4
|
|
ANTI-HUMAN MIP-1ALPHA
|
|
|
|
|
ANTI-HUMAN V-BETA12-FITC
|
|
|
|
|
ANTI-HLA-DR, BIOTIN
|
|
|
|
|
ANTI-HUMAN IGA, G, M RHODAMINE
|
|
|
|
|
6-(9-anthryl)-2-benzoyl-4-methyl-1,5,2-dioxazinane
|
|
309277-64-3
|
C25H21NO3
|
|
ANTI-HUMAN CD116, PE
|
|
|
|
|
4-[2-(9-anthrylmethylene)hydrazino]-N-(2,4-dichlorophenyl)-4-oxobutanamide
|
|
356563-44-5
|
C25H19Cl2N3O2
|
|
9,10-anthracenedithiol
|
|
86756-29-8
|
C14H10S2
|
|
2-[4-(9-anthrylmethylene)-2,5-dioxoimidazolidin-1-yl]-N-(4-methylphenyl)acetamide
|
|
664353-10-0
|
C27H21N3O3
|
|
5-(9-anthryl)-2,7-dimethyl-5,6-dihydropyrazolo[1,5-c]quinazoline
|
|
667873-61-2
|
C26H21N3
|
|
3-[(9-anthrylmethylene)amino]-2-methyl-4(3H)-quinazolinone
|
|
352338-51-3
|
C24H17N3O
|
|
9-anthracenecarbaldehyde [1,2,4]triazolo[4,3-b]pyridazin-6-ylhydrazone
|
|
352286-75-0
|
C20H14N6
|
|
4-(9-anthrylmethylene)-1-(3,4-dichlorophenyl)-3,5-pyrazolidinedione
|
|
353780-80-0
|
C24H14Cl2N2O2
|
|
6-(9-anthryl)-3-(ethylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine
|
|
|
C26H20N4OS
|
|
5-(9-anthrylmethylene)-3-(3-chlorophenyl)-2-thioxo-1,3-thiazolidin-4-one
|
|
313964-60-2
|
C24H14ClNOS2
|
|
9-anthracenecarbaldehyde [4-(4-methoxyphenyl)-1,3-thiazol-2-yl]hydrazone
|
|
|
C25H19N3OS
|
|
9-anthracenecarbaldehyde (5,5-dimethyl-4-oxo-1,3-thiazolidin-2-ylidene)hydrazone
|
|
663197-41-9
|
C20H17N3OS
|
|
9-anthracenecarbaldehyde (1-phenyl-1H-tetraazol-5-yl)hydrazone
|
|
383164-72-5
|
C22H16N6
|
|
9-anthracenecarbaldehyde (5-methyl-4-oxo-1,3-thiazolidin-2-ylidene)hydrazone
|
|
342397-93-7
|
C19H15N3OS
|
|
9-anthracenecarbaldehyde [3-phenyl-4,5-bis(phenylimino)-1,3-thiazolidin-2-ylidene]hydrazone
|
|
666820-48-0
|
C36H25N5S
|
|
9-anthracenecarbaldehyde [4,6-di(1-piperidinyl)-1,3,5-triazin-2-yl]hydrazone
|
|
292075-16-2
|
C28H31N7
|
|
2-[2-(9-anthrylmethylene)hydrazino]-N-(2-naphthyl)-2-oxoacetamide
|
|
|
C27H19N3O2
|
|
ANTI-HUMAN IGA, G, M ALK PHOS
|
|
|
|
|
ANTHRACENE-D10 SOLUTION 100UG/ML IN METHANOL 1ML
|
|
|
C14H9D
|
|
2-({6-[(9-anthrylmethylene)amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-1,3-benzothiazol-6-yl]acetamide
|
|
312265-52-4
|
C32H22N4OS4
|
|
9-anthryl(2-thienyl)methanol
|
|
327070-32-6
|
C19H14OS
|
|
Anthranilic acid, 5-chloro-, heptyl ester
|
|
18189-09-8
|
|
|
9,10-Anthracenedione, 1-((4-(diethylamino)-1-methylbutyl)amino)-
|
|
69658-02-2
|
C23H28N2O2
|
|
ANTI-HUMAN IGG, CY2 CONJUGATE
|
|
|
|
|
ANTI-HUMAN PLASMIN A-CHAIN
|
|
|
|
|
[6-(9-anthryl)-2-benzoyl-1,5,2-dioxazinan-4-yl]methyl phenyl ether
|
|
381682-74-2
|
C31H25NO4
|
|
4-[2-(9-anthrylmethylene)hydrazino]-N-(2-chlorophenyl)-4-oxobutanamide
|
|
356766-14-8
|
C25H20ClN3O2
|
|
5-(9-anthrylmethylene)-1-(4-methylphenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
|
|
|
C26H18N2O3
|
|
5-(9-anthrylmethylene)-2-thioxo-1,3-thiazolidin-4-one
|
|
|
C18H11NOS2
|
|
5-(9-anthrylmethylene)-1-(4-chlorophenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
|
|
|
C25H15ClN2O3
|
|
9-anthracenecarbaldehyde (4-(dibutylamino)-6-{4-nitroanilino}-1,3,5-triazin-2-yl)hydrazone
|
|
232935-69-2
|
C32H34N8O2
|
|
3-(9-anthrylmethylene)-5-(2,5-dimethylphenyl)-2(3H)-furanone
|
|
350503-86-5
|
C27H20O2
|
|
1-[(9-anthrylmethylene)amino]-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
|
|
|
C23H17N3O
|
|
[5-(9-anthrylmethylene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid
|
|
|
C20H13NO3S2
|
|
anthracene-9-carbaldehyde 5H-[1,2,4]triazino[5,6-b]indol-3-ylhydrazone
|
|
324030-04-8
|
C24H16N6
|
|
3-[(9-anthrylcarbonyl)amino]benzoic acid
|
|
|
C22H15NO3
|
|
2-(9-anthryl)-7-tert-butyl-2,3,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
|
|
|
C28H28N2OS
|
|
5-(9-anthrylmethylene)-1-(3,4-dimethylphenyl)-3-phenyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione
|
|
352335-91-2
|
C33H24N2O2S
|
|
5-(9-anthrylmethylene)-2-{[3-(trifluoromethyl)phenyl]imino}-1,3-thiazolidin-4-one
|
|
486995-36-2
|
C25H15F3N2OS
|
|
2-({6-[(9-anthrylmethylene)amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-dibenzo[b,d]furan-3-ylacetamide
|
|
|
C36H23N3O2S2
|
|
2-[5-(9-anthrylmethylene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(2-fluorophenyl)acetamide
|
|
508185-07-7
|
C26H17FN2O3S
|
|
9-anthracenecarbaldehyde [4-{4-nitroanilino}-6-(4-methoxyanilino)-1,3,5-triazin-2-yl]hydrazone
|
|
|
C31H24N8O3
|
|
9-anthracenecarbaldehyde N-(1-adamantyl)semicarbazone
|
|
348101-62-2
|
C26H27N3O
|
|
ANTI-HUMAN BLOOD GROUP ANTIGEN H - TYPE 2
|
|
|
|
|
ANTI-HUMAN CD45R/B220 BIOTIN CONJUGATED
|
|
|
|
|
9-anthracenecarbaldehyde [4-anilino-6-(diethylamino)-1,3,5-triazin-2-yl]hydrazone
|
|
339160-28-0
|
C28H27N7
|
|
11-(9-anthryl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one
|
|
352691-00-0
|
C29H26N2O
|
|
ANTI-HTRA2/OMI
|
|
|
|
|
Anthracene, tetradecahydro-
|
十四氢蒽
|
6596-35-6
|
C14H24
|
|
ANTI-HUMAN HMB45, MELANOSOME EPOS, HRP
|
|
|
|
|
ANTHRAQUINONE-2-CARBOXYLIC ACID
|
蒽醌-2-羧酸
|
117-78-2
|
C15H8O4
|
|
ANTI-HUMAN P53 FITC CONJUGATE, AA 20-25
|
|
|
|
|
ANTI-HUMAN ACTIVIN RIIB EXTRACELLULAR DOMAIN, BIOTIN
|
|
|
|
|
ANTI-HUMAN SURVIVIN/TIAP (CT)
|
|
|
|
|
Anthra(2,3-b)furan-5,10-dione, 2,3-dihydro-4,6,8-trihydroxy-3-(2-hydro xyethyl)-
|
|
74277-84-2
|
C18H14O7
|
|
ANTI-HUMAN CD87 DOMAIN I
|
|
|
|
|
9,10-ANTHRACENEDIONE, 1-(beta-D-GLUCOPYRANOSYLOXY)-4-HYDROXY-
|
|
39115-11-2
|
|
|
ANTI-HUMAN HARAKIRI AA 47 - 66
|
|
|
|
|
3-(9-ANTHRYL)-1-(4-BROMOPHENYL)PROP-2-EN-1-ONE, TECH
|
|
|
C23H15BrO
|
|
2-(3-(anthracen-9-ylmethyl)-1H-imidazol-3-ium-1-yl)acetate
|
1－羧基-3-（9-蒽甲基）咪唑内盐
|
|
C20H16N2O2
|
|
ANTHRAQUINONE-2,6-DISULFONIC ACID, DISODIUM SALT, MIXTURE OF ISOMERS, TECH., 90
|
蒽醌二磺酸二钠
|
84-50-4
|
C14H8O8S2
|
|
ANTI-HUMAN TRAIL, CLONE B-S23, MONOCLONAL ANTIBODY, PE
|
|
|
|
|
anthra[1,9-ab]naphtho[2,3-i]carbazole-5,13,18(17H)-trione
|
|
40349-99-3
|
C31H15NO3
|
|
ANTI-HUMAN MCP-1, PE
|
|
|
|
|
ANTI-HUMAN KERATIN 20
|
ANTI-HUMAN KERATIN 20
|
|
|
|
ANTI-HUMAN CD45/CD14/HLA-DR
|
|
|
|
|
ANTI-HUMAN CD179A
|
ANTI-HUMAN CD179A
|
|
|
|
ANTI-HUMAN CD99 FITC
|
|
|
|
|
ANTI-HLA-DR+DP (HUMAN)
|
|
|
|
|
ANTI HUMAN HS90BETA
|
|
|
|
|
ANTI-HPV 11
|
|
|
|
|
ANTHRISCUS CEREFOLIUM EXTRACT
|
蜡叶峨参(ANTHRISCUS CEREFOLIUM)提取物
|
|
|
|
ANTI-HUMAN V-BETA 3 TCR
|
|
|
|
|
ANTI-HUMAN IGG (GAMMA-CHAIN SPECIFIC)-R-PHYCOERYTHRIN
|
|
|
|
|
ANTI-HUMAN IL-6 RECEPTOR ALPHA SUBUNIT
|
|
|
|
|
Anthraquinone-1,5-Disulphonic Acid Sodium Salt
|
蒽醌-1,5-二磺酸钠
|
|
C14H6Na2O8S2
|
|
ANTI HUMAN CYTOCHROME P450 3A4/5
|
|
|
|
|
Anthraquinone-1-Sulphonic Acid Ammonium Salt
|
|
|
C14H11NO5S
|
|
Anthraquinone Series dyes and pigments intermedaites
|
|
|
|
|
Anthracene Compounds
|
|
|
|
|
2-Anthracenesulfonic acid, 1-amino-4-[[3-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2,4,6-trimethyl-5-sulfophenyl]amino]-9,10-dihydro-9,10-dioxo-, potassium sodium salt
|
|
94157-80-9
|
C68H54Cl2K3N14Na3O28S8
|
|
9-anthracenecarbaldehyde [2,6-di(1-pyrrolidinyl)-4-pyrimidinyl]hydrazone
|
|
345615-96-5
|
C27H28N6
|
|
2-[5-(9-anthrylmethylene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(3-methylphenyl)acetamide
|
|
|
C27H20N2O3S
|
|
ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR-C
|
|
|
|
|
ANTHRACENE SOLUTION 100 NG/MYL
|
蒽
|
|
C14H10
|
|
ANTI-HUMAN LYMPHOTACTIN, BIOTINYLATED
|
|
|
|
|
ANTI-HUMAN LEWIS Y
|
|
|
|
|
ANTI-HUMAN CD62P
|
|
|
|